The success of retinal gene therapy for Leber’s congenital amaurosis patients was assessed by researchers using a multimodal imaging approach in a study published in the Science Translational Medicine journal this month
The success of retinal gene therapy for Leber’s congenital amaurosis patients was assessed by researchers using a multimodal imaging approach in a study published in the Science Translational Medicine journal this month.
Findings suggested that visual experience, enhanced by gene therapy, may be responsible for the re-organisation and maturation of synaptic connectivity in the visual pathways of the brain for those treated. The results were compared to the untreated eye of LCA patients.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here